Abbott Introduces Alinity Diagnostics Systems in the United States
The Alinity family of systems feature high throughput and an integrated, common interface across the lab, within a minimized footprint.
Read MorePosted by Melissa Mayer | Aug 17, 2018 | Clinical Chemistry, Immunoassay, Molecular Diagnostics, Point-of-Care, Research |
The Alinity family of systems feature high throughput and an integrated, common interface across the lab, within a minimized footprint.
Read MorePosted by Melissa Mayer | Aug 10, 2018 | Immunoassay, Infectious Diseases, Research |
For patients with complex health situations, clinical metagenomics may open the door to actionable results quickly enough to inform medical decisions.
Read MorePosted by Melissa Mayer | Aug 6, 2018 | Software |
The ASI Evolution facilitates laboratories’ use of CDC’s traditional nontreponemal screening algorithm with a fully automated assay that increases efficiency and output.
Read MorePosted by Melissa Mayer | Aug 6, 2018 | Research, Sepsis |
A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
Read MorePosted by Melissa Mayer | Aug 6, 2018 | Leukemia, Software |
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read More